App-Quantinova.ai

Low testosterone and erectile function in male patients with type 2 diabetes

Eugen Luchytskiy - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Male Sexual Dysfunction

Alora

Glargine insulin treatment during pregnancy in type 1 diabetes mellitus

Rafael Palomares-Ortega - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

Insulin glargine

The effect of metformin on spontaneous apoptosis in patients with type 2 diabetes

Kondratska Iryna - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

sulfonylureas

Remitting seronegative symmetrical synovitis with pitting oedema syndrome in association with saxagliptine: case report

Mine Adas - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

Prednisone

Metabolic status in patients with type 1 diabetes mellitus

Elena Vashchenko - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

The effect of compensation of diabetes on ulcer healing in patients with diabetic foot syndrome

Maksym Prystupiuk - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic foot

N/A

Lixisenatide improves glycaemic control and body composition in uncontrolled type 2 diabetic patients treated with insulin

Carmen Ayala - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Lixisenatide

Liraglutide improves ?-cell function, measured by the C-peptide/glucose ratio, in obese patients with type 2 diabetes

Miguel A Rubio - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Liraglutide

Study of irisin hormone level in type 2 diabetic patients with and without diabetic neuropathy

Manal Abushady - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic neuropathy

N/A

Occurrence frequency of diabetic foot syndrome in three pilot regions of Uzbekistan

Telman Kamalov - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic foot

N/A

Different stress hormone response in insulin pump treatment compared with multiple daily injection: preliminary data

Jacopo Pareo - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

Androgen Tear

Evaluating analogue vs human insulin efficacy in real life: observational study in type 2 Albanian diabetic patients, previously insulin treated

Gjinal Gjoncaj - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Analogue insulin

Telemedicine as a motivational tool to optimise metabolic control in patients with diabetes in Turkey: results from a randomised controlled trial

Elif Bagdemir - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Long-term tele-monitoring of patients with type 2 diabetes mellitus: ancillary analysis of the results of the Greek pilot of the renewing health multicentre randomised control trial

Afentoula Mavrodi - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Education for diabetes self-management improves quality of life and reduces HbA1c levels in people with diabetes

Elvisa Sokoli - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Prevalence of microalbuminuria and predictive factors in a group of Albanian diabetic adults

Mimoza Ismaili - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic nephropathy

Albuman

Glycaemic control and weight evolution in type 2 diabetic patients with dapagliflozina in addition to their previous treatment

Maria Cristina Crespo Soto - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Pregnancy planning in type 1 diabetes mellitus

Rafael Palomares-Ortega - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Microvascular complications of diabetes 1

N/A

Web-based telemedicine system is useful for monitoring glucose control in pregnant women with diabetes

Florentino Carral San Laureano - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Gestational Diabetes

N/A

Changes in diabetes related quality of life and clinical outcomes in patients with type 2 diabetes, after initiation of injectable treatment

Georgios Georgas - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Insulin glargine

Filters

4759 Abstracts